ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 279.00
-16.00 (-5.42%)
Jul 16, 2026, 2:00 PM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 20.08 billion as of July 16, 2026. Its market cap has increased by 818.95% in one year.
Market Cap
20.08B
Enterprise Value
19.12B
Revenue
38.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
279.00
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 20.08B, an increase of 1,927.37%. That is a compound annual growth rate of 83.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 20.08B | 397.07% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
| Jul 27, 2021 | 990.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 24.30B |
| CHO Pharma | 22.26B |
| Sunmax Biotechnology | 20.75B |
| TaiMed Biologics | 17.84B |
| Ever Supreme Bio Technology | 16.64B |
| Lumosa Therapeutics | 16.15B |
| Medigen Vaccine Biologics | 15.71B |
| TCM Biotech International | 14.70B |